A variant on chromosome 2p13.3 is associated with atopic dermatitis in Chinese Han population.

  title={A variant on chromosome 2p13.3 is associated with atopic dermatitis in Chinese Han population.},
  author={Xingjun Cai and Xiao-dong Zheng and Ling Fang and Fusheng Zhou and Yujun Sheng and Yan-Yan Wu and Chong-xian Yu and Jun Zhu and Fengli Xiao},

Figures and Tables from this paper

Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review

Filaggrin (FLG) polymorphisms are confirmed as key genetic determinants for AD development, but also epigenetic regulation and other genes with functions mainly related to the immune system and extracellular matrix are reinforced, reinforcing the notion of skin homeostasis breakage in AD.

IL1R1 Polymorphisms are Associated with Lumbar Disc Herniation Risk in the Northwestern Chinese Han Population

  • Yong ZhuShunan Li Xuejun Yang
  • Biology, Medicine
    Medical science monitor : international medical journal of experimental and clinical research
  • 2019
It is demonstrated that genetic variants in the IL1R1 genes were associated with LDH risk in the Han population of northwestern China.

The Role of Genetics, the Environment, and Epigenetics in Atopic Dermatitis.

Epigenetic studies provide a connection between the relationship of an impaired skin barrier and immune and environmental factors, such as tobacco exposure, pollutants, microbes, and diet and nutrients, which contribute to the pathogenesis of AD.

Epigenetics in Allergy and Autoimmunity

With the development of drugs that target the specific epigenetic mechanisms involved in the regulation of gene expression, development and utilization of epigenetic tools are an appropriate and effective approach that can be clinically applied to the treatment of various diseases.

Staphylococcus aureus wall teichoic acid is a pathogen-associated molecular pattern that is recognized by langerin (CD207) on skin Langerhans cells

It is demonstrated that human LCs directly interact with S. aureus through the pattern-recognition receptor langerin (CD207), providing molecular insight into the unique pro-inflammatory capacities of S.aureus in relation to inflammatory skin disease.

Wall teichoic acid is a pathogen-associated molecular pattern of Staphylococcus aureus that is recognized by langerin (CD207) on skin Langerhans cells

It is demonstrated that human LCs directly interact with S. aureus through the pattern-recognition receptor langerin (CD207), which specifically recognizes the conserved β-N-acetylglucosamine modifications of wall teichoic acid (WTA) modifications of WTA that are not expressed by other staphylococcal species.

Langerhans Cells Sense Staphylococcus aureus Wall Teichoic Acid through Langerin To Induce Inflammatory Responses

It is demonstrated that human LCs directly interact with S. aureus through the pattern recognition receptor langerin (CD207), a receptor unique to LCs, and these findings provide molecular insight into the unique proinflammatory capacities of S.Aureus in relation to skin inflammation.



A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis

It is indicated that the pathogenesis of AD incorporates immune and epidermal barrier defects with combinations of specific and overlapping effects at individual loci, and the genetic relationship between AD, asthma and psoriasis is explored by examining previously identified susceptibility SNPs for these diseases.


A genome-wide association meta-analysis of affected individuals and controls and the ten most strongly associated new susceptibility loci examined underline the importance of both epidermal barrier function and immune dysregulation in atopic dermatitis pathogenesis.

Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis

Ten new risk loci are identified for atopic dermatitis, bringing the total number of known atopic skin disease susceptibility loci to 31 (with new secondary signals at four of these loci), underscoring the important contribution of (auto)immune mechanisms to atopy dermatitis pathogenesis.

A common variant on chromosome 11q13 is associated with atopic dermatitis

Highly significant association was found with allele A of rs7927894 on chromosome 11q13.5, located 38 kb downstream of C11orf30, and their risk of developing atopic dermatitis is 1.47 times that of noncarriers.

Genome-wide association study of recalcitrant atopic dermatitis in Korean children.

Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population

The findings advance the understanding of the genetic basis of atopic dermatitis and replicate the associations of the FLG, C11orf30, TMEM232-SLC25A46, TNFRSF6B-ZGPAT, OVOL1, ACTL9 and KIF3A-IL13 loci that were previously reported in GWAS of European and Chinese individuals.

Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population

This study identifies new genetic susceptibility factors and suggests previously unidentified biological pathways in atopic dermatitis, which is a chronic, relapsing form of inflammatory skin disorder that is affected by genetic and environmental factors.

High-density genotyping study identifies four new susceptibility loci for atopic dermatitis

The number of atopic dermatitis risk loci reported in individuals of European ancestry is increased to 11, and it is estimated that these susceptibility loci together account for 14.4% of the heritability for atopy dermatitis.

HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease

A use case of HaploReg is illustrated for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putative brain regulatory mechanisms, and the number of chromatin state maps to 127 reference epigenomes is greatly expanded.

Recent developments in atopic dermatitis

  • W. PengN. Novak
  • Biology, Medicine
    Current opinion in allergy and clinical immunology
  • 2014
Better knowledge of atopic dermatitis pathways will form the basis for the development of rationale-based therapeutic approaches in the future.